• FDA Compliance for Food Contact Materials: Migration Risk, FCN/GRAS & Informed Compliance Decisions

    Advanced FDA compliance training for food contact materials covering migration risk, FCN/GRAS pathways, and informed regulatory decisions for professionals.

6 Month Access

Get full access to the complete training for 6 months

Training Certificate

Demonstrate your expertise with a subject-specific training certificate

Training Materials

Download training materials including presentation slides, Q&A, and FAQ PDFs

Expert Connect

Connect with the expert via discussion forum to clarify technical questions

FDA compliance for food contact materials rarely breaks at the obvious level. Most teams can navigate listings, supplier declarations, and basic regulatory checks. The real difficulty starts when decisions have to be made across pathways, exposure assumptions, and system-level behaviour under FDA food contact regulations (21 CFR), where the line between compliant and non-compliant is not always clearly defined. In practice, compliance is shaped by how materials behave within the final application. Migration logic, regulatory pathways, and documentation strategy all interact, and small misinterpretations at this stage often lead to delays, rework, or rejected submissions.


FDA compliance for food contact materials is not a documentation exercise. It is a technical risk decision that determines whether materials enter the U.S. market smoothly or fail late due to migration concerns, incorrect clearance pathways, or weak regulatory justification. This training is designed for professionals who already work with food contact materials and need to understand how the FDA evaluates safety, migration, and compliance decisions in practice, not just what regulations exist. 

The focus is on migration risk, FCN and GRAS pathways, regulatory boundaries, and the judgment calls that most often lead to delays, rework, or rejection. Participants will gain clarity on how FDA interprets migration data, exposure thresholds, functional barriers, and formulation changes, and how these factors influence approval strategy and long-term compliance. The training also addresses common misapplications of exemptions, clearance routes, and testing assumptions that experienced teams still get wrong. 

This is not an introductory FDA overview. It is an advanced, decision-focused training for professionals responsible for making, reviewing, or defending FDA compliance decisions for food contact materials.

Why You Should Not Miss This Training:

This training aims to provide a comprehensive decision making ability for the regulatory framework enforced by the U.S FDA for food contact materials. Participants can gain knowledge on;

  1. Avoid Late-Stage Regulatory Failures: Understand why FDA compliance issues surface late and how migration risk is often underestimated.
  2. Choose the Right Clearance Pathway: Clarify when FCN, GRAS, TOR, or exemptions apply and where misuse creates approval risk.
  3. Interpret Migration Data the Way FDA Does: Learn how FDA evaluates exposure, thresholds, and safety relevance beyond test results.
  4. Strengthen Compliance Decisions, Not Just Documentation: Move from rule awareness to defensible, regulator-ready decision making.
  5. Reduce Rework, Delays, and Market Access Risk: Identify common compliance misjudgments that cause costly reformulation or submission delays


Who Should Attend:

This training is intended for professionals responsible for FDA compliance, material approval, or regulatory decision-making related to food contact materials in particular:

  • Regulatory affairs professionals working with FDA food contact materials
  • R&D chemists and materials scientists supporting compliant formulations
  • Quality and compliance managers responsible for regulatory justification
  • Technical managers and directors overseeing FDA approval strategies
  • Professionals involved in migration assessment, clearance selection, or compliance

Frequently asked questions
  1. Why does FDA compliance for food contact materials often become complicated beyond regulatory listings?
    Because compliance decisions depend on how the material is used, not just how it is listed.
  2. Why is choosing the right FDA clearance pathway not always straightforward?
    Different pathways involve different assumptions, timelines, and risks that are not always obvious early in development.
  3. Why do migration and exposure assessments create uncertainty in compliance decisions?
    Because evaluation depends on how the material behaves under specific use conditions, not just on test data alone.
  4. Why do some projects face delays even after completing required testing?
    Because regulatory expectations extend beyond testing and include interpretation, documentation, and justification.
  5. Why do functional barrier assumptions not always hold during compliance review?
    Because real-world behaviour of materials can differ from initial theoretical expectations.
  6. Why is FDA compliance considered a strategic decision rather than just a regulatory requirement?
    Because early decisions in formulation, pathway selection, and documentation directly affect timelines, cost, and approval outcomes.

Trainers List

Course Curriculum

Get Started Now!